(Q45866219)

17 December 2017

http://europepmc.org/abstract/MED/24953131

title

Genetic factors influencing inhibitor development in a cohort of South African haemophilia A patients (English)

1 reference

17 December 2017

http://europepmc.org/abstract/MED/24953131

0 references

0 references

0 references

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24953131%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Amanda Krause

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24953131%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

author name string

A Lochan

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24953131%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

S Macaulay

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24953131%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

J N Mahlangu

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24953131%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

publication date

21 June 2014

1 reference

17 December 2017

http://europepmc.org/abstract/MED/24953131

published in

Haemophilia

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24953131%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24953131%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24953131%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

page(s)

687-692

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24953131%20AND%20SRC:MED&resulttype=core&format=json

Haemophilia A: database of nucleotide substitutions, deletions, insertions and rearrangements of the factor VIII gene

9 June 2020

cites work

1 reference

The Italian AICE-Genetics hemophilia A database: results and correlation with clinical phenotype

21 January 2018

1 reference

F8 gene mutation type and inhibitor development in patients with severe hemophilia A: systematic review and meta-analysis

21 January 2018

1 reference

Influence of the type of F8 gene mutation on inhibitor development in a single centre cohort of severe haemophilia A patients.

21 January 2018

1 reference

Inversions disrupting the factor VIII gene are a common cause of severe haemophilia A

21 January 2018

1 reference

Recombinant factor VIII in the management of hemophilia A: current use and future promise

21 January 2018

1 reference

Understanding inhibitor development in haemophilia A: towards clinical prediction and prevention strategies

21 January 2018

1 reference

Cost of care and quality of life for patients with hemophilia complicated by inhibitors: the COCIS Study Group

21 January 2018

1 reference

Clinical prediction models for inhibitor development in severe hemophilia A.

21 January 2018

1 reference

21 January 2018

1 reference

Inhibitors of factor VIII in black patients with hemophilia

21 January 2018

1 reference

F8 and F9 mutations in US haemophilia patients: correlation with history of inhibitor and race/ethnicity

21 January 2018

1 reference

F8 haplotype and inhibitor risk: results from the Hemophilia Inhibitor Genetics Study (HIGS) Combined Cohort

21 January 2018

1 reference

Factor VIII gene explains all cases of haemophilia A

21 January 2018

1 reference

The Malmö International Brother Study (MIBS): further support for genetic predisposition to inhibitor development in hemophilia patients

21 January 2018

1 reference

A case-control study reveals immunoregulatory gene haplotypes that influence inhibitor risk in severe haemophilia A.

21 January 2018

1 reference

Incidence of factor VIII inhibitors in severe haemophilia: the importance of patient age.

21 January 2018

1 reference

21 January 2018

1 reference

Intensive exposure to factor VIII is a risk factor for inhibitor development in mild hemophilia A.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/HAE.12436

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24953131%20AND%20SRC:MED&resulttype=core&format=json

release_zye2vzxcibgzzlexmnvrqr3pl4

9 June 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/zye2vzxcibgzzlexmnvrqr3pl4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24953131%20AND%20SRC:MED&resulttype=core&format=json